Literature DB >> 12587076

Molecular characterization of an Enterovirus 71 causing neurological disease in Germany.

Johannes Kehle1, Bernhard Roth, Christoph Metzger, Artur Pfitzner, Gisela Enders.   

Abstract

Enterovirus 71 (EV71) is mainly known as a cause of hand-foot-and-mouth disease (HFMD) but sometimes associated with neurological disease, even as fatal brainstem encephalitis. In Europe, EV71 infections are extremely rare, in contrast to the worldwide situation. This is the first report of molecular characterization of an EV71 strain isolated in Europe that had caused neurological disease. The german strain is closest related to sublineage B2 strains isolated in the United States, which where mainly associated with neurological disease. Phylogenetic analysis also showed that the strain must have been imported to Germany several years ago, and continues to circulate since then.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12587076     DOI: 10.1080/13550280390173364

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  8 in total

1.  Molecular detection and identification of enteroviruses using enzymatic amplification and nucleic acid hybridization.

Authors:  N M Chapman; S Tracy; C J Gauntt; U Fortmueller
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

Review 2.  Fatal enterovirus type 71 infection: rapid detection and diagnostic pitfalls.

Authors:  M L Landry; S N Fonseca; S Cohen; C W Bogue
Journal:  Pediatr Infect Dis J       Date:  1995-12       Impact factor: 2.129

3.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

4.  Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia.

Authors:  P McMinn; K Lindsay; D Perera; H M Chan; K P Chan; M J Cardosa
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

6.  An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.

Authors:  M Ho; E R Chen; K H Hsu; S J Twu; K T Chen; S F Tsai; J R Wang; S R Shih
Journal:  N Engl J Med       Date:  1999-09-23       Impact factor: 91.245

7.  Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998.

Authors:  B A Brown; M S Oberste; J P Alexander; M L Kennett; M A Pallansch
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

8.  Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group.

Authors:  L G Chan; U D Parashar; M S Lye; F G Ong; S R Zaki; J P Alexander; K K Ho; L L Han; M A Pallansch; A B Suleiman; M Jegathesan; L J Anderson
Journal:  Clin Infect Dis       Date:  2000-10-04       Impact factor: 9.079

  8 in total
  25 in total

Review 1.  Host factors in enterovirus 71 replication.

Authors:  Shin-Ru Shih; Victor Stollar; Mei-Ling Li
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

2.  Clinical and etiological characteristics of enterovirus 71-related diseases during a recent 2-year period in Korea.

Authors:  Wi-Sun Ryu; Byounghak Kang; Jiyoung Hong; Seoyeon Hwang; Jonghyun Kim; Doo-Sung Cheon
Journal:  J Clin Microbiol       Date:  2010-05-12       Impact factor: 5.948

3.  Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3.

Authors:  Xiaobo Lei; Zhenmin Sun; Xinlei Liu; Qi Jin; Bin He; Jianwei Wang
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

4.  Sumoylation-promoted enterovirus 71 3C degradation correlates with a reduction in viral replication and cell apoptosis.

Authors:  Shu-Chuan Chen; Luan-Yin Chang; Yi-Wei Wang; Yi-Chun Chen; Kuo-Feng Weng; Shin-Ru Shih; Hsiu-Ming Shih
Journal:  J Biol Chem       Date:  2011-07-22       Impact factor: 5.157

5.  The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses.

Authors:  Xiaobo Lei; Xinlei Liu; Yijie Ma; Zhenmin Sun; Yaowu Yang; Qi Jin; Bin He; Jianwei Wang
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

6.  Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany.

Authors:  Holger F Rabenau; Matthias Richter; Hans Wilhelm Doerr
Journal:  Med Microbiol Immunol       Date:  2009-11-26       Impact factor: 3.402

7.  Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006.

Authors:  Jon M Bible; Miren Iturriza-Gomara; Brian Megson; David Brown; Panagiotis Pantelidis; Pam Earl; Justin Bendig; C Y William Tong
Journal:  J Clin Microbiol       Date:  2008-07-23       Impact factor: 5.948

8.  Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71.

Authors:  Tzu-Chun Chen; Hwan-You Chang; Pei-Fen Lin; Jyh-Haur Chern; John Tsu-An Hsu; Chu-Yi Chang; Shin-Ru Shih
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

9.  Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation.

Authors:  Kuo-Feng Weng; Mei-Ling Li; Chuan-Tien Hung; Shin-Ru Shih
Journal:  PLoS Pathog       Date:  2009-09-25       Impact factor: 6.823

10.  Population dynamics and genetic diversity of C4 strains of human enterovirus 71 in Mainland China, 1998-2010.

Authors:  Dawei Guan; Sabine van der Sanden; Hanri Zeng; Wei Li; Huanying Zheng; Cong Ma; Juan Su; Zheng Liu; Xue Guo; Xin Zhang; Leng Liu; Marion Koopmans; Changwen Ke
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.